<DOC>
	<DOCNO>NCT02130726</DOCNO>
	<brief_summary>Laparoscopic surgery show provide important advantage comparison open procedure treatment several malignant disease , less peri-operative blood loss , faster patient recovery shorter hospital stay . All maintain similar result regard tumour resection margin oncological survival . In gastric cancer role laparoscopic surgery remain unclear . Current recommend treatment gastric cancer consist radical resection stomach , combine lymfadenectomy . The extent lymfadenectomy consider marker radicality surgery quality care . Therefore , It imperative new surgical technique non-inferior regard radicality lymph node yield . Preliminary study show promising result laparoscopic gastrectomy , number study small due low incidence gastric cancer West often underpowered . A prospective randomise clinical trial indicate order establish optimal surgical technique gastric cancer : open versus minimally invasive gastrectomy . Results STOMACH trial aid determine optimal surgical technique patient gastric cancer .</brief_summary>
	<brief_title>Surgical Technique , Open Versus Minimally-invasive Gastrectomy After CHemotherapy</brief_title>
	<detailed_description />
	<mesh_term>Stomach Neoplasms</mesh_term>
	<criteria>Age equal 18 year Primary adenocarcinoma stomach , indication total gastrectomy curative intent . Neoadjuvant therapy ( epirubicin , cisplatin , capecitabine ) Surgical resectable ( T13 , N01 , M0 ) Informed consent Previous coexist cancer Previous surgery stomach ASA classification ( American Society Anaesthesiologists ) score 4 high</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Gastric cancer</keyword>
	<keyword>Minimally-invasive</keyword>
	<keyword>Oncological quality resection</keyword>
</DOC>